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Purpose: To report the clinical phenotype in patients with a retinal dystrophy associated with novel mutations in the MER
tyrosine kinase (MERTK) gene.
Methods: A consanguineous family of Middle Eastern origin was identified, and affected members underwent a full
clinical evaluation. Linkage analysis was performed using the Affymetrix 50K chip. Regions of homozygosity were
identified. The positional candidate genes protocadherin 21 (PCDH21), retinal G protein-coupled receptor (RGR), and
MERTK were polymerase chain reaction (PCR) amplified and sequenced. Long-range PCR was performed to characterize
the deletion. Two hundred and ninety-two probands with autosomal recessive, childhood onset, retinal dystrophies were
analyzed using the Asper Ophthalmics Leber congenital amaurosis chip to screen for known MERTK mutations.
Results: Analysis of a 50K-Affymetrix whole genome scan identified three regions of homozygosity on chromosomes 2
and 10. Screening of the candidate gene MERTK showed a possible deletion of exon 8. Long-range PCR identified a ~9
kb deletion within MERTK that removes exon 8. Screening of DNA from a panel of Saudi Arabian patients with autosomal
recessive retinitis pigmentosa identified a second consanguineous family with the same mutation. One patient with a known
MERTK mutation (p.R651X) was identified using the Asper Ophthalmics Leber congenital amaurosis chip. Further
screening of the gene identified a second novel splice site mutation in intron 1. The phenotype associated with these
identified MERTK mutations is of a childhood onset rod–cone dystrophy with early macular atrophy. The optical coherence
tomography (OCT) appearance is distinctive with evidence of debris beneath the sensory retina.
Conclusions: Mutations in MERTK are a rare cause of retinal dystrophy. Non homologous recombination between Alu
Y repeats near or within disease genes may be an important cause of retinal dystrophies.
Retinitis pigmentosa (RP) describes a group of disorders
with progressive degeneration of rod and cone photoreceptors
in a rod–cone pattern of dysfunction. RP has a prevalence of
1  in  3,500  [1].  It  is  genetically  and  phenotypically
heterogeneous, with all three forms of Mendelian inheritance
having been reported. Autosomal recessive RP (ARRP) is the
most common form, accounting for more than half of all cases
of RP [2]. To date, mutations in 25 genes have been associated
with ARRP, with a further four mapped loci (RetNet).
MER tyrosine kinase (MERTK), a member of the Axl/
Mer/Tyro3  receptor  tyrosine  kinase  family  required  for
phagocytosis and expressed in the retinal pigment epithelium
(RPE) [3], was first implicated in retinal degeneration in 2000
when a deletion in the gene was identified in the Royal College
of  Surgeons  (RCS)  rat  [4].  Gal  et  al.  [5]  subsequently
identified three different mutations in patients with recessive
retinal dystrophies. However, in comparison to other genes
involved in retinal dystrophies, the reporting of new mutations
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in MERTK has been slow, with only a further five mutations
having been described since the initial study [6-11].
The  present  report  describes  the  clinical  phenotype
associated with two novel mutations in MERTK.
METHODS
Clinical investigations: Two 10 ml EDTA tubes of peripheral
venous blood were drawn from all available family members,
including  both  affected  and  unaffected  individuals,  and
samples  were  frozen.  DNA  was  extracted  using  the
Nucleon™ BACC-2 genomic DNA kit (GE Healthcare Life
Sciences,  Buckinghamshire,  UK).  Following  cell  lysis,
deproteinization was performed using sodium perchlorate.
DNA  extraction  was  achieved  with  chloroform  and
Nucleon™ resin before DNA recovery and washing.
All patients involved in this study provided informed
consent as part of a research project approved by Moorfields
Eye hospital and King Faisal Specialist Hospital research
ethics committee, and all investigations were conducted in
accordance with the principles of the Declaration of Helsinki.
Clinical  evaluation  including  slit-lamp  examination,
assessment of visual acuity, color vision, and perimetry were
performed. Color vision was evaluated using the Hardy-Rand-
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369Rittler (HRR) plates (American Optical Company, New York,
NY) and the 24-plate Ishihara color vision test (Kanehara and
Co. Ltd, Tokyo, Japan). Patients underwent retinal imaging,
including  fundus  autofluorescence  imaging  (FAF),  with
confocal scanning laser ophthalmoscopy (Heidelberg Retina
Angiograph 2 [HRA2]; Heidelberg Retina Angiograph OCT
[HRA-OCT];  Heidelberg  Engineering,  Heidelberg,
Germany). Full-field and pattern electroretinography (ERG
and  PERG)  were  performed  with  gold  foil  recording
electrodes incorporating the International Society for Clinical
Electrophysiology of Vision (ISCEV) Standards [12,13]
Apex  chip:  A  genomic  DNA  sample  from  292  unrelated
affected patients with Leber congenital amaurosis (LCA) or
childhood onset RP was sent to Asper Ophthalmics Ltd for
analysis, as described previously [14,15].
Autozygosity  mapping:  Genome-wide  linkage  scan  were
performed on family A to identify regions of autozygosity
(where both alleles are identical by descent and are copies of
a common ancestral gene). DNA samples from all affected
family members were genotyped using the Affymetrix human
GeneChip® Mapping 50K XbaI Array (Affymetrix, Santa
Clara, CA). The detailed methodology for genotyping using
the GeneChip® array has been previously described [16].
Briefly, 250 ng of genomic DNA was digested with XbaI
(New England Biolabs, Ipswich, MA) for 2 h at 37 °C, ligated
with  XbaI  adaptors  using  T4  DNA  ligase  (New  England
Biolabs,  Hitchin,  Herts,  UK).  The  ligation  reaction  was
diluted  in  1:4  (v/v)  with  molecular  grade  water  (Sigma-
Aldrich, St. Louis, MO) to 100 µl. Ten µl of the diluted
ligation mix was used to set up selection by PCR (Fragment
Selection by PCR) in triplicates. The pooled PCR products
were purified using QIAGEN MinElute 96 UF plate (Qiagen,
Duesseldorf, Germany). The concentration of PCR products
was  quantified  using  ND-1000  Nanodrop  spectrometry
(Thermo  Fisher  Scientific,  Waltham,  MA).  Purified  PCR
product  (90  ng)  was  fragmented  with  0.25  units  DNaseI
('Fragmentation  Reagent';  Affymetrix),  labeled  with
'Labeling Regent' (Affymetrix). The labeling reaction (70 µl)
was mixed with 190 μl hybridization reagent and denatured at
99 °C for 10 min (all as detailed in the Affymetrix GeneChip
Mapping  100K  Assay  Manual).  Finally  the  denatured
hybridization mixture was injected into Affymetrix Human
Mapping XbaI chips and incubated at 48 °C for 16 h, followed
by automatic washing and staining in a Fluidics Station 450,
and  scanned  by  using  the  GeneChip®  Scanner  3000  7G
(Affymetrix).  Genotypes  for  single  nucleotide
polymorphisms (SNPs) were called by the GeneChip DNA
Analysis Software (GDAS version 3.0, Affymetrix). A macro
was  written  in  Visual  Basic  within  the  Microsoft  Excel
(Microsoft,  Redmond,  WA)  program  to  detect  genomic
regions showing regions of shared haplotype.
Mutation screening: Primers to amplify the coding exons and
the  intron–exon  boundaries  of  MERTK,  protocadherin  21
(PCDH21), and retinal protein-coupled receptor (RGR) were
used  as  previously  described  [10,17,18].  All  PCR  were
performed in a total volume of 30 μl containing 200 μM
deoxynucleotide triphosphate (dNTPs; VH Bio, Gateshead,
UK), 20 μM of each primer, 1× reaction buffer (10× PCR
buffer: 600 mM Tris-sulfate [pH 9.1], 180 mM ammonium
sulfate, 15 mM magnesium sulfate; VH Bio) with 1 unit of
Moltaq (VH Bio) and 100 ng of DNA. PCR was performed
on a PTC200 DNA engine thermal cycler (Bio-Rad, Hemel
Hempstead, UK).
PCR  products  were  visualized  on  a  2%  agarose  gel
containing  0.05%  ethidium  bromide.  The  products  were
cleaned using multiscreen PCR filter plates (Catalogue no
LSKMPCR10; Millipore, Watford, UK) before sequencing.
PCR products were sequenced directly using ABI Prism Big
Dye Terminator kit (ABI Ltd, Warrington, Cheshire, UK;
version 3.1) in a 10-μl reaction. Samples were purified using
the Montage cleanup kit (catalog no LSK509624; Millipore)
before being run on an ABI Applied Biosystems 3730 DNA
sequencer.
Long-range PCR was used to determine the size of the
deletion. PCR primers were designed ranging from intron 7
(7F2, 5′-TGC TGA TAT TCT AGT AGC CAA GTG G-3′)
of the MERTK gene to intron 8 (8R5, 5′-ACA TTT CTC TGA
CAT GAG GTG GTC TG-3′). A total of 12.5 μl of Extensor
Hi-Fidelity PCR Master Mix (Abgene, Epson, UK) was added
to a 12.5-μl mixture containing water, 250 ng of template
DNA, and 200 nM of each primer. Thermal cycling conditions
for long-range PCR were an initial denaturation of 2 min at
94 °C was followed by 10 cycles of 94 °C for 10 s, 60 °C for
30 s and 68 °C for 8 min. This was followed by 20 cycles of
94 °C for 10 s, 60 °C for 30 s and 68 °C for 8 min adding 10
s on every cycle.
RESULTS
Case report: Subject 1. The proband of family A (individual
IV:2),  a  26-year-old  male  of  Middle  Eastern  origin,  was
diagnosed with rod–cone dystrophy at the age of 16. There
was no significant history of systemic disease. He first noticed
difficulties with night vision and visual field loss at the age of
9 years; reduced central vision was noted at 13 years. When
examined at age 26, visual acuity was 1.78 logarithm of the
minimum angle of resolution (LogMAR) in each eye. He was
unable to recognize any of the plates of the HRR color vision
test. Fundus examination revealed pale optic discs, attenuated
retinal  vessels,  macular  atrophy,  and  peripheral  retinal
atrophy  with  intraretinal  pigmentary  deposition  extending
into  the  posterior  pole  in  each  eye  (Figure  1A).  FAF
demonstrated  a  large  central  area  of  decreased
autofluorescence  along  with  more  widespread  peripheral
areas of reduced signal in both eyes (Figure 1B). Spectralis
spectral-domain  OCT  (SD-OCT)  imaging  (Figure  1C)
revealed disruption of the normal laminar arrangement at the
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370Figure 1. Color fundus composite showing fundus autofluorescence (FAF) and spectral domain OCT (SD-OCT) for patients 1, 2, and 3. Patient
1 (Family A, Individual IV:2) at age 28: fundus image (A) shows well circumscribed macular atrophy, vascular attenuation, disc pallor, and
peripheral pigment migration. FAF (B) using high gain demonstrates the absence of macular autofluorescence. SD-OCT (C) reveals thinning
of the photoreceptor layer and wrinkling of the outer limiting membrane, with multiple high reflectance bodies visible in residual outer nuclear
layer. Patient 2 (Family A, Individual IV: 5) at age 12: fundus image (D) shows early macular atrophy and peripheral pigment migration. FAF
(E) reveals limited parafoveal hyperfluorescence with low total autofluorescence. SD-OCT (F) reveals thinning of the photoreceptor layer,
with discrete hyper-reflective bodies below the outer limiting membrane. Fundus composite (G) of patient 3 at age 23 shows foveal and
parafoveal yellow discoloration but minimal peripheral pigmentation. FAF (H) demonstrates hypofluorescence at the fovea and SD-OCT
(I) shows thinning of the photoreceptor layer and high reflectance bodies.
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371photoreceptor/RPE interface and loss of the outer limiting
membrane.  Discrete  hyper-reflective  bodies  were  visible
within  the  outer  nuclear  layer.  Significant  loss  of  retinal
volume and foveal atrophy could be observed. Mean retinal
thickness of the central Early Treatment Diabetic Retinopathy
Study (ETDRS) subfield (CSF) was 182 µm for the right and
165 µm for the left eyes (normal value 270±22.5 µm [19]),
and central point thickness (CPT) was 70 µm for the right and
64 µm for the left eyes (normal value 227.3±23.2 µm [19]).
Subject  2.  This  8-year-old  boy  (IV:5),  the  younger
brother of subject 1, was diagnosed with rod–cone dystrophy
at the age of 8 years. Parents reported him having difficulty
seeing in the dark from an early age. His best corrected visual
acuities were 0.32 LogMAR in each eye. He had a low myopic
refractive  error  (−2.00  OU)  and  mild  generalized
dyschomatopsia on testing with the HRR color vision test.
Visual fields were reduced to 20–30° in each eye. Fundus
examination revealed mild macular RPE changes in a “bull’s-
eye” pattern, with retinal atrophy and intraretinal pigmentary
deposition in the periphery (Figure 1D). There was some
residual  macular  autofluorescence  on  FAF  (Figure  1E).
Spectralis OCT (Figure 1F) revealed disruption of the normal
foveal inner segment/outer segment (IS/OS) boundary, and
smaller hyper-reflective bodies both at the level of the IS/OS
junction and in the outer nuclear layer. There was reduced
retinal  thickness  at  the  fovea,  with  a  mean  CSF  retinal
thickness of 169 µm for the right and 160 µm for the left eyes
(normal value 270 ±22.5 µm [19]). CPT was 138 µm for the
right  and  130  µm  for  the  left  eyes  (normal  value
227.3±23.2 µm [19]).
Subject 3. This 22-year-old male of Caucasian origin was
diagnosed with rod–cone dystrophy at the age of 14. He had
a strong family history of red–green color blindness (affecting
maternal uncle and grandfather and two cousins) and also a
family history of deafness (affecting mother, maternal uncle,
and grandmother). There was no consanguinity, no family
history  of  retinal  dystrophy,  and  no  history  of  systemic
disease. He had normal hearing. He noticed nyctalopia at age
12 and developed sensitivity to light soon after. At age 22,
visual  acuities  were  0.6  LogMAR  in  the  right  and  1.0
LogMAR in the left eyes. He had a mild refractive error (OD
+0.25/–1.50x120, OS +0.25/–1.00x95) and very poor color
vision.  Goldman  visual  fields  performed  at  age  19  were
reported to be full. Fundus examination revealed focal atrophy
in the central macula and a mild diffuse abnormality of the
RPE at the posterior pole but very little intraretinal pigment.
Retinal  vessels  were  thinned  (Figure  1G).  FAF  imaging
demonstrated  a  half-disc-diameter-sized  central  area  of
hyperfluorescence, encircled by an area of relatively reduced
autofluorescence  (Figure  1H).  Spectralis  OCT  revealed
significant loss of the photoreceptor layer. Mean CSF retinal
thickness was 196 µm for the right and 202 µm for the left
eyes (normal value 270±22.5 µm [19]). CPT was less than
130 µm in both eyes (normal value 227.3±23.2 µm [19]).
Multiple small hyper-reflective bodies could be observed at
the level of the IS/OS junction.
Electroretinography was performed at age 16 and 21. In
the initial recordings the full-field rod-specific ERGs were
undetectable: to a red flash under dark adaptation there was a
clear and delayed cone component but no rod component;
bright flash ERGs showed a markedly delayed and subnormal
a-wave, with a slightly lower amplitude b-wave, and probably
arose from residual cones; cone-derived photopic single flash
and flicker ERGs were severely delayed and were subnormal.
The  findings  at  aged  21  showed  no  definite  clinically
significant  deterioration.  Pattern  ERGs  on  both  occasions
showed possible low-amplitude residual signals but suggested
severe bilateral macular involvement.
Figure 2. Diagram showing the genomic
layout surrounding MERTK exon 8 in
the normal and deleted chromosomes in
Family  A.  Primers  used  in  the
amplification of the deletions are shown
by the arrows (labeled 7F2 and 8R5).
The position of Alu Y repeats are shown
by a red triangle.
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372Genome scan: Results of the Affymetrix 50K genome scan on
family A revealed three shared regions of homozygosity. Two
regions were found on chromosome 2: 2q12-q21 covering 30
Mb in size, a region containing the candidate gene MERTK;
and 2p13.2-p11.2 covering 16 Mb. An 8-Mb region on 10q23
contained two candidate genes known to be expressed in the
eye, RGR and PCDH21. All three possible candidate genes
were screened for mutations [5,17,18]. No sequence changes
segregating with disease were found in RGR and PCDH21.
When screening MERTK, all exons apart from exon 8
amplified,  and  sequencing  showed  no  disease-causing
mutations. Only one SNP was seen in the family; rs13027171
(G>A S475N) was heterozygous in individual III:2. All other
members of the family were homozygous for the common G
allele. PCRs containing exon 8 did not work for either of the
affected siblings but worked in control DNA. New primers
situated 500 bp either side of exon 8 were designed to rule out
a sequence change where the primers annealed. The PCR
worked for all unaffected members of the family but not the
affected siblings.
A DNA walking PCR-based experiment was designed to
cover the area between exon 7 and exon 9 (18,778 bp) to
determine if there was a deletion of exon 8. Long-distance
PCR between two primers, 7F2 (situated in intron 7) and 8R5
(situated in intron 8), amplified a 9.86-kb product in control
samples.  When  the  same  region  was  amplified  from  the
affected siblings, the PCR produced a band of 917 bp instead
of the control 9.86 kb, suggesting deletion of exon 8 along
with the majority of introns 7 and 8 (Figure 2). Removal of
exon 8 is predicted to disrupt the reading frame of MERTK,
leading to a premature stop codon in exon 9. Both parents and
three unaffected siblings amplified both the large and the
small  fragment  (Figure  3).  SNP  haplotyping  of  the  area
surrounding the deletion confirmed that each parent was a
carrier of the haplotype containing the deletion, as were the
unaffected siblings. Both affected siblings were homozygous
for all SNPs studied (Figure 4).
Sequence analysis of the 917-bp PCR product showed it
did not contain exon 8. The PCR product contained unique
DNA from both intron 7 and 8 at each end and included a
complete Alu Y repeat in its center. By blasting this PCR
product sequence, we identified that 664 bp were identical to
the DNA upstream from primer 8R5 (located in intron 8). The
first 389 bp of this was unique to intron 8, with a complete
Alu Y repeat making up the remainder of the homology. The
remaining 253 bp of the PCR product was unique to intron 7.
Downstream from this 253 bp in genomic sequence is another
Alu  Y  repeat,  suggesting  nonhomologous  recombination
between repeats as a possible cause for the deletion.
Figure 3. Gel electrophoresis results for
long range PCR in family A. Long range
PCR  (using  primers  7F2  and  8R5)
showing the normal product of 9.65 kb
and the deleted product of 917 bp in
Family  A.  The  two  affected  products
(IV:2, IV:5) are missing the upper 9.65-
kb band.
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373Screening  of  100  unrelated  probands  with  autosomal
recessive retinal dystrophies collected in the UK, using the
PCR described above, failed to identify a similar deletion.
Screening  of  100  probands  with  RP  from  Saudi  Arabia
identified a second family with recessive RP with the same
exon  8  deletion.  Affected  members  of  the  family  were
homozygous for the deletion. Haplotype analysis showed that
these two families shared a region of at least 500 kb based on
the two makers D2S160 and D2S1896 (chr2:112,309,575–
112,815,205). This deletion was not seen in 100 control DNA
samples from Saudi Arabia. This additional family was not
available for detailed phenotyping. A review of the clinical
records showed that there were five affected individuals with
childhood onset RP. Visual acuity ranged from 20/50 in the
first decade to hand movements by the third decade. There
was  macular  atrophy  present  from  the  first  decade  and
extensive peripheral atrophy and pigmentation.
Screening of MERTK in Leber congenital amaurosis patients:
Screening 292 probands with either LCA or childhood onset
retinal dystrophy, using the Asper LCA mutation chip [15],
identified a single patient with a known MERTK mutation.
Analysis  of  the  LCA  chip  data  of  subject  3  revealed  the
presence of the known mutation p.R651X caused by a C to T
transition in exon 14 [5]. This was the only sequence variant
identified by the chip. Direct sequencing of the gene in this
patient confirmed the p.R651X change and also revealed a G
to  A  sequence  change  in  the  first  base  of  intron  1  (c.
61+1G>A).  This  novel  change  is  predicted  to  disrupt  the
donor splice site of intron 1. Analysis of this novel change
using an automated splice site analysis predictor program
[20] revealed that the mutation would eradicate the use of the
true donor splice site, with the cellular splicing mechanism
favoring the use of potential splice sites further downstream.
A site 33 bp downstream from the mutation was predicted to
be used. The extra 33 bp in exon 1 would not disrupt the frame
but would insert 11 new codons into the transcript. Other
potential splice sites (4 bp and 24 bp downstream from the
true site) would cause a change of the reading frame leading
to a stop codon in exon 2. These two mutations were shown
to have been inherited from each parent and were not seen in
100 ethnically matched controls (data not shown).
DISCUSSION
Mutations in MERTK are a rare cause of retinal dystrophy in
humans.  The  present  report  describes  two  novel  disease-
causing mutations identified in a large cohort of children with
LCA and childhood onset rod–cone dystrophy. We identified
a  large  deletion  in  MERTK  affecting  members  of  a
consanguineous family with ARRP. Linkage was established
to  the  MERTK  region  by  a  genome-wide  scan  using  an
Affymetrix SNP chip. Direct sequencing of the coding exons
did not identify a single base change, but long-range PCR
revealed a 9-kb deletion resulting in the removal of exon 8.
The deletion occurred between two Alu Y repeats. Alu repeats
are characterized by sequences approximately 300 bp long
with a poly (A) tract of variable length and flanking direct
repeats.  Over  one-third  of  the  human  genome  contains
Figure  4.  Haplotype  analysis  of  the
single  nucleotide  polymorphism
(SNP’s) surrounding the MER protein
kinase  (MERTK)  gene  in  Family  A.
Haplotyped  pedigree  of  Family  A
showing the segregation of the deletion
with  the  surrounding  SNPs  (rs  ID
numbers to the left of the haplotype)
used to map the family to this region.
The proband (IV:2, patient 1) is marked
by an arrow. The black bar represents
the disease haplotype.
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375repetitive interspersed sequences that were once transposable
elements.  Alu  sequences  are  the  second  most  common
element (after LINE-1 elements), representing more than 5%
of the genome [21].
Analysis of the MERTK locus identified a total of ten Alu
Y  repeats;  nonhomologous  recombination  involving  other
Alu Y repeats could therefore be involved in other MERTK-
associated  retinal  dystrophies.  Large  deletions  in  disease
genes are susceptible to being missed when using direct DNA
sequencing, especially if they are in an individual who is a
compound  heterozygote.  Nonhomologous  recombination
between  Alu  repeats  is  a  frequent  cause  of  deletions  and
insertions in the human genome [22]. Such recombination
events have been associated with inherited disease in several
cases, including eye disorders, such as X-linked retinoschisis
[23] and retinitis punctata albescens [24].
Screening  of  patients  with  LCA  and  childhood  onset
retinal dystrophies using the Asper Ophthalmics LCA chip
allowed us to identify a further patient with a previously
reported MERTK mutation. The Asper Ophthalmics LCA chip
[14,15] contains known mutations and polymorphisms from
LCA genes but has a limited number of variants in MERTK.
Direct  sequencing  of  coding  exons  revealed  a  splice  site
mutation in the first base of intron 1. In silico analysis using
a splice site analysis predictor program suggested that this
would reduce the effectiveness of the donor splice site. The
next strongest potential site, if used, would introduce 11 amino
acids into the protein but would not disrupt the frame of the
active protein kinase domain. The other potential sites would
lead to a premature stop codon in exon 2, thus eliminating
most of the protein’s active domains and thus rendering it
inactive. As this is early in the transcript, we predicted that
these  altered  transcripts  would  be  degenerated  through
nonsense-mediated  decay  (NMD).  NMD  is  a  potential
outcome  in  transcripts  where  an  early  stop  codon  is
recognized. Only when the premature stop codon occurs in
the last coding exon or the last 55 bp of the preceding exon
are these transcripts protected from NMD [25]. It is possible
that NMD may occur in family A as the deletion of exon 8
leads to a premature stop codon in exon 9.
To  date,  six  families  have  been  reported  with  retinal
disease due to MERTK mutations (Table 1) [5-11]. Gal et al.
[5], in their initial report of MERTK mutations in human
disease, described three patients with MERTK mutations. All
three individuals had a severe retinal dystrophy of childhood
onset, but few details of the phenotype are given. Subsequent
reports [8,10,26] included more clinical details. McHenry et
al. [8] reported a single case with a severe rod–cone dystrophy
symptomatic at age 3 years. By age 9 there was nystagmus,
severe visual field constriction, and an undetectable ERG.
Tschernutter et al. [10] reported three affected individuals
from a consanguineous family from the Middle East who had
a homozygous null mutation. Affected individuals reported
night  blindness  from  early  childhood,  with  subsequent
reduction  in  central  vision.  The  rod  ERG  was  severely
abnormal  at  diagnosis  with  later  cone  involvement.  The
pattern ERG was abnormal early in the disease. An interesting
feature of the disease was the well preserved peripheral field.
Charbel Issa et al. [26] have recently reported similar findings
in five affected individuals from a consanguineous Moroccan
family. The two affected members of our family A have a
phenotype similar to the individuals reported by Tschernutter
et al. [10] and Charbel Issa et al. [26], with early onset of night
blindness,  early  rod  ERG  reduction,  and  early  macular
atrophy. Our third patient had a milder overall phenotype with
later  onset  of  disease.  However,  he  shows  the  typical
characteristic  of  early  macular  atrophy  and  relative
preservation of peripheral visual fields. Spectral domain OCT
shows  loss  of  photoreceptors  and  hyper-reflective  bodies
possibly analogous to the debris layer seen in the RCS rat.
Similar  spectral  domain  OCT  changes  were  reported  by
Charbel Issa et al. [26]. These changes as well as a wavelike
appearance of the innermost neurosensory retina might be
distinctive  OCT  findings  in  patients  with  mutations  in
MERTK.
The phenotype associated with MERTK mutations is of a
childhood  onset  rod–cone  dystrophy  with  early  macular
atrophy. The OCT appearance is distinctive and may help
guide  targeted  molecular  genetic  analysis  for  the
identification of patients with MERTK mutations. The retinal
dystrophy seen in the animal model of MERTK-related disease
(the  RCS  rat)  has  been  successfully  rescued  with  gene
replacement therapy [27]. It is evident from the findings in our
patients and others reported in the literature that there is a
window  of  opportunity  for  therapeutic  intervention  in
childhood. This makes MERTK an excellent target for gene
therapy in humans, and the early identification of patients will
be important for their inclusion in future clinical trials.
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